pharmaceutical investing Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial
pharmaceutical investing Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
Tartisan Nickel Corp. Announces Rodren Drilling has Commenced Drilling at the Kenbridge Nickel Copper Cobalt Project, Sioux Narrows, Northwestern, Ontario
Momentum Builds, Upside Appears as Mining Explorers Transition Toward Production, Unlock Major Hidden Value
